The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

R Dhanasekaran, A Deutzmann… - Nature reviews Clinical …, 2022 - nature.com
The MYC proto-oncogenes encode a family of transcription factors that are among the most
commonly activated oncoproteins in human neoplasias. Indeed, MYC aberrations or …

ERK signalling: a master regulator of cell behaviour, life and fate

H Lavoie, J Gagnon, M Therrien - Nature reviews Molecular cell biology, 2020 - nature.com
The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream
components of a phosphorelay pathway that conveys growth and mitogenic signals largely …

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

SE Ahmadi, S Rahimi, B Zarandi, R Chegeni… - Journal of hematology & …, 2021 - Springer
MYC oncogene is a transcription factor with a wide array of functions affecting cellular
activities such as cell cycle, apoptosis, DNA damage response, and hematopoiesis. Due to …

An update of epigenetic drugs for the treatment of cancers and brain diseases: a comprehensive review

Z Sahafnejad, S Ramazi, A Allahverdi - Genes, 2023 - mdpi.com
Epigenetics has long been recognized as a significant field in biology and is defined as the
investigation of any alteration in gene expression patterns that is not attributed to changes in …

Interplay between cell death and cell proliferation reveals new strategies for cancer therapy

LV Loftus, SR Amend, KJ Pienta - International journal of molecular …, 2022 - mdpi.com
Cell division and cell death are fundamental processes governing growth and development
across the tree of life. This relationship represents an evolutionary link between cell cycle …

The role of chaperone-mediated autophagy in cell cycle control and its implications in cancer

M Andrade-Tomaz, I de Souza, C Ribeiro Reily Rocha… - Cells, 2020 - mdpi.com
The cell cycle involves a network of proteins that modulate the sequence and timing of
proliferation events. Unregulated proliferation is the most fundamental hallmark of cancer; …

[HTML][HTML] PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression

M Liu, B Yao, T Gui, C Guo, X Wu, J Li, L Ma, Y Deng… - Theranostics, 2020 - ncbi.nlm.nih.gov
The proto-oncogene c-Myc regulates multiple biological processes mainly through
selectively activating gene expression. However, the mechanisms underlying c-Myc …

RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

W Feng, DC Dean, FJ Hornicek… - Therapeutic …, 2020 - journals.sagepub.com
Background: Over the past four decades, outcomes for osteosarcoma patients have
plateaued as there have been few emerging therapies showing clinical results. Thus, the …

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation

AE Schade, M Fischer, JA DeCaprio - Nucleic Acids Research, 2019 - academic.oup.com
Cell cycle gene expression occurs in two waves. The G1/S genes encode factors required
for DNA synthesis and the G2/M genes contribute to mitosis. The Retinoblastoma protein …

The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer

M Pieraccioli, C Caggiano, L Mignini, C Zhong… - Nature structural & …, 2022 - nature.com
Alternative polyadenylation (APA) yields transcripts differing in their 3′-end, and its
regulation is altered in cancer, including prostate cancer. Here we have uncovered a …